These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 38031200)

  • 1. Bacteriophage-based approach for treatment of urinary tract infections: a quick outlook.
    Grygorcewicz B; Gliźniewicz M; Jabłońska J; Augustyniak A; Olszewska P; Wojciuk B; Miłek D; Serwin N; Czajkowski A; Cecerska-Heryć E; Rakoczy R; Cymbaluk-Płoska A
    APMIS; 2024 Feb; 132(2):81-93. PubMed ID: 38031200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteriophages: a Panacea in Neuro-Urology?
    Leitner L; Kessler TM; Klumpp J
    Eur Urol Focus; 2020 May; 6(3):518-521. PubMed ID: 31732462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriophage therapy for
    Bhargava K; Nath G; Dhameja N; Kumar R; Aseri GK; Jain N
    Future Microbiol; 2023 Apr; 18():323-334. PubMed ID: 37140267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and Characterization of Novel Lytic Phages Infecting Multidrug-Resistant Escherichia coli.
    Vera-Mansilla J; Sánchez P; Silva-Valenzuela CA; Molina-Quiroz RC
    Microbiol Spectr; 2022 Feb; 10(1):e0167821. PubMed ID: 35171030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial.
    Leitner L; Ujmajuridze A; Chanishvili N; Goderdzishvili M; Chkonia I; Rigvava S; Chkhotua A; Changashvili G; McCallin S; Schneider MP; Liechti MD; Mehnert U; Bachmann LM; Sybesma W; Kessler TM
    Lancet Infect Dis; 2021 Mar; 21(3):427-436. PubMed ID: 32949500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomized, placebo-controlled, double-blind clinical trial.
    Leitner L; Sybesma W; Chanishvili N; Goderdzishvili M; Chkhotua A; Ujmajuridze A; Schneider MP; Sartori A; Mehnert U; Bachmann LM; Kessler TM
    BMC Urol; 2017 Sep; 17(1):90. PubMed ID: 28950849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phage Resistance Accompanies Reduced Fitness of Uropathogenic Escherichia coli in the Urinary Environment.
    Zulk JJ; Clark JR; Ottinger S; Ballard MB; Mejia ME; Mercado-Evans V; Heckmann ER; Sanchez BC; Trautner BW; Maresso AW; Patras KA
    mSphere; 2022 Aug; 7(4):e0034522. PubMed ID: 35920561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phage Therapy as a Protective Tool Against Pathogenic Bacteria: How Far We Are?
    Singh K; Biswas A; Chakrabarti AK; Dutta S
    Curr Pharm Biotechnol; 2023; 24(10):1277-1290. PubMed ID: 36503459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriophage therapy for inhibition of multi drug-resistant uropathogenic bacteria: a narrative review.
    Chegini Z; Khoshbayan A; Vesal S; Moradabadi A; Hashemi A; Shariati A
    Ann Clin Microbiol Antimicrob; 2021 Apr; 20(1):30. PubMed ID: 33902597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of fluoroquinolones in the treatment of serious bacterial urinary tract infections.
    Carson C; Naber KG
    Drugs; 2004; 64(12):1359-73. PubMed ID: 15200349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Empirical Antibiotic Therapy on Outcomes of Outpatient Urinary Tract Infection Due to Nonsusceptible
    Dunne MW; Puttagunta S; Aronin SI; Brossette S; Murray J; Gupta V
    Microbiol Spectr; 2022 Feb; 10(1):e0235921. PubMed ID: 35138150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on the management of urinary tract infections in the era of antimicrobial resistance.
    Bader MS; Loeb M; Brooks AA
    Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriophages: the possible solution to treat infections caused by pathogenic bacteria.
    El-Shibiny A; El-Sahhar S
    Can J Microbiol; 2017 Nov; 63(11):865-879. PubMed ID: 28863269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Possibilities of bacteriophage therapy].
    Skurnik M; Kiljunen S
    Duodecim; 2016; 132(8):712-9. PubMed ID: 27244930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteriophage treatment as an alternative therapy for multidrug-resistant bacteria.
    Alqahtani A
    Saudi Med J; 2023 Dec; 44(12):1222-1231. PubMed ID: 38016738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteriophage therapy for management of bacterial infections in veterinary practice: what was once old is new again.
    Squires RA
    N Z Vet J; 2018 Sep; 66(5):229-235. PubMed ID: 29925297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Phage Cocktail Therapy of the Urinary Tract Infection in a Mouse Model.
    Mijbel Ali B; Gatea Kaabi SA; Al-Bayati MA; Musafer HK
    Arch Razi Inst; 2021 Nov; 76(5):1229-1236. PubMed ID: 35355758
    [No Abstract]   [Full Text] [Related]  

  • 18. Bacteriophages as therapeutic agents.
    Sulakvelidze A; Morris JG
    Ann Med; 2001 Nov; 33(8):507-9. PubMed ID: 11730156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prospects of using bacteriophages in urological practice].
    Shiryaev AA; Vasilyev AO; Zaitsev AV; Prilepskaya EA; Sazonova NA; Grigoryan IE; Kim YA; Pushkar DY
    Urologiia; 2019 Dec; (6):131-136. PubMed ID: 32003183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reapproaching Old Treatments: Considerations for PK/PD Studies on Phage Therapy for Bacterial Respiratory Infections.
    Schmalstig AA; Freidy S; Hanafin PO; Braunstein M; Rao GG
    Clin Pharmacol Ther; 2021 Jun; 109(6):1443-1456. PubMed ID: 33615463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.